Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04374071 · ClinicalTrials.gov registry record
Early Short Course Corticosteroids in COVID-19
A clinical trial of COVID and Pneumonia, Viral, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04374071 is a study of COVID and Pneumonia, Viral that has completed, run by Henry Ford Health System. The registered enrollment target is 250 participants, below the 2,585-participant average among 14 other COVID trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04374071, a study of COVID and Pneumonia, Viral, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators intend to study the role of early use of methylprednisolone in the hospitalized patients with a diagnosis of COVID-19 pneumonia.
Conditions Studied
Interventions
- DRUG Methylprednisolone
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-03-12 |
| Est. Completion | 2020-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04374071
The ClinicalTrials.gov registry entry for NCT04374071 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,585-participant average among 14 other COVID trials with a reported enrollment target (90% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COVID appearing as the primary indexed condition, and to 1 intervention - of which Methylprednisolone is the first listed.
NCT04374071 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04374071 about?
NCT04374071 is a clinical study titled "Early Short Course Corticosteroids in COVID-19". The investigators intend to study the role of early use of methylprednisolone in the hospitalized patients with a diagnosis of COVID-19 pneumonia.
What is the current status of trial NCT04374071?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2020-03-12. Estimated completion is 2020-04-30.
What conditions does trial NCT04374071 study?
This clinical trial studies the following conditions: COVID, Pneumonia, Viral.
What interventions are being tested in trial NCT04374071?
The interventions under investigation include: Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT04374071?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04374071 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
RECRUITING
-
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
RECRUITING · NA
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
RECRUITING
-
COVID-19 Biorepository
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.